Concepedia

A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis

Harald Hefter, Andreas Kupsch, Martina Müngersdorf, Sebastian Paus, Andrea Stenner, Wolfgang H. Jost

BMJ Open · 2011 · 34 citations · 9 references

DOIFull text

Open access

Abstract

Dysport 500 U is effective and well tolerated for the de novo management of a range of heterogeneous forms of CD, when using a standardised regimen that allows tailored dosing based on individual symptom assessment. Clinical trials information (NCT00447772; clinicaltrials.gov).

References

9

DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS

JosephK.C Tsui, A. Jon Stoessl, Andrew Eisen et al. · The Lancet · 1986 · 808 citations

, , +1

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study

Daniel Truong, Drake D. Duane, Joseph Jankovic et al. · Movement Disorders · 2005 · 240 citations

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport 

Werner Poewe, Günther Deuschl, A Nebe et al. · Journal of Neurology Neurosurgery & Psychiatry · 1998 · 217 citations · Full text

Long‐term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

Mitchell F. Brin, Cynthia Comella, Joseph Jankovic et al. · Movement Disorders · 2008 · 202 citations

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

Daniel Truong, Matthew Brodsky, Mark Lew et al. · Parkinsonism & Related Disorders · 2010 · 150 citations

, ,